Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Netherlands-Canada Type 2 Diabetes Consortium - Travel Award - General

University of British Columbia

$3,000.00

Mechanisms of beta cell dysfunction in type 2 diabetes

EF 2019-20

Résumé
In type 2 diabetes, insulin production by cells in the pancreas called beta cell declines, resulting in rising blood sugars. The loss of insulin production is due to the death of beta cella as well as progressive worsening of the function of surviving beta cells. Our research aims to understand the mechanisms that lead to beta cell dysfunction in type 2 diabetes. We believe that this is driven by inflammation and the accumulation of toxic products within the pancreas, including immune cells, protein aggregates, bacteria, and certain products of metabolism and diet, including fats. My current collaborations with Dutch researchers are investigating some of these pathways, with the goal of developing therapies that could slow the progressive loss of insulin secretion in type 2 diabetes.
Programme
Netherlands-Canada Type 2 Diabetes Consortium - Travel Award - General
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
415833
Name
Verchere Bruce C
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Biomedical
Prcname2
Netherland-Canada Type 2 Diabetes Consortium - Travel Award
Projecttitle
Mechanisms of beta cell dysfunction in type 2 diabetes
Programtype2
Undefined
Orgnameinp2
University of British Columbia
Cihramount2
$3,000
Cihrequipment2
$0
Programname2
Netherlands-Canada Type 2 Diabetes Consortium - Travel Award - General
Keyworddelim
Amyloid; Beta Cell; Cholesterol; Iapp; Infection; Inflammation; Insulin; Islet; Macrophages; Type 2 Diabetes
Abstract
In type 2 diabetes, insulin production by cells in the pancreas called beta cell declines, resulting in rising blood sugars. The loss of insulin production is due to the death of beta cella as well as progressive worsening of the function of surviving beta cells. Our research aims to understand the mechanisms that lead to beta cell dysfunction in type 2 diabetes. We believe that this is driven by inflammation and the accumulation of toxic products within the pancreas, including immune cells, protein aggregates, bacteria, and certain products of metabolism and diet, including fats. My current collaborations with Dutch researchers are investigating some of these pathways, with the goal of developing therapies that could slow the progressive loss of insulin secretion in type 2 diabetes.
Competitiondate
201909
Approvedterm2
1 yr 0 mth
Pinamesdelim
Verchere, Bruce C
Approvedterm
1 an 0 mois
Cihrcontribution2
Inst of Nutr Metabolism &Diab~ $3,000~ $0~